                         SEQUENCE LISTING

<110>  AstraZeneca AB
 
<120>  Method for treating lung cancer

<130>  200764-WO-PCT

<150>  JP 2018-043943
<151>  2018-03-12

<160>  4     

<170>  PatentIn version 3.5

<210>  1
<211>  18
<212>  DNA
<213>  Artificial Sequence

<220>
<223>  primer

<400>  1
cctcacctcc accgtgca                                                     18


<210>  2
<211>  16
<212>  DNA
<213>  Artificial Sequence

<220>
<223>  primer

<400>  2
aggcagccga agggca                                                       16


<210>  3
<211>  14
<212>  DNA
<213>  Artificial Sequence

<220>
<223>  probe for wild type


<220>
<221>  misc_feature
<222>  (2)..(2)
<223>  locked nucleic acid

<220>
<221>  misc_feature
<222>  (6)..(8)
<223>  locked nucleic acid

<220>
<221>  misc_feature
<222>  (9)..(10)
<223>  modified by ZEN

<220>
<221>  misc_feature
<222>  (11)..(11)
<223>  locked nucleic acid

<400>  3
tcatcacgca gctc                                                         14


<210>  4
<211>  14
<212>  DNA
<213>  Artificial Sequence

<220>
<223>  probe for T790M mutant


<220>
<221>  misc_feature
<222>  (2)..(2)
<223>  locked nucleic acid

<220>
<221>  misc_feature
<222>  (6)..(8)
<223>  locked nucleic acid

<220>
<221>  misc_feature
<222>  (9)..(10)
<223>  modified by ZEN

<220>
<221>  misc_feature
<222>  (11)..(11)
<223>  locked nucleic acid

<220>
<221>  misc_feature
<222>  (13)..(13)
<223>  locked nucleic acid

<400>  4
tcatcatgca gctc                                                         14


